Preprints Could Be an Incentive for Open Collaboration Among Scientific Researchers
The recent threat of severe cutbacks to the NIH, which could still occur, was unnerving to scientific researchers. This makes the best case for opening…
Blog
Open Therapeutics and the Center for Advancing Innovation Form Partnership
Minneapolis, MN and Bethesda, MD (PRWEB) April 20, 2017 Open Therapeutics and the Center for Advancing Innovation announce the formation of a unique intellectual property…
Recognition for Scientific Discovery, an Added Inducement to Use OpenTherapeutics.net
Alice Augusta Ball was an African American pharmacologist and chemist in the early 20th Century who developed the only effective treatment for Hansen’s Disease (leprosy)…
Scientific Collaboration Can Help Solve the Quagmire Triggered by Costly Prescription Drug and Therapy Research
While a morass of market forces seems to defy any practical solution to high drug prices, not to mention stakeholders with unreasonable profit margins, it…
Odds of Bringing Therapeutic Drugs to Market Increase with Collaboration
One of the most tragic inherited red blood cell disorders, to which mostly children are vulnerable, is sickle cell anemia — a condition in which…
Bioresearch Collaboration Will Speed Development of New Therapies and Mitigate High Drug Prices
This fall, Open Therapeutics (OT) expects to debut an elegant platform that will allow scientists and researchers to collaborate on all aspects of Bioresearch and…
The Science of Childhood Cancer
An Introduction to the Science of Cancer educational video of pediatric cancers, by Timothy P. Cripe, MD, PhD, Open Therapeutics’ Viral Oncolytics Advisor and Chief of…
Immunotherapy – “Most Exciting Development in Cancer Treatment in Years”
Immunotherapy has been referred to as the “most exciting development in cancer treatment in years” (Guardian, 2015). When treatments such as chemotherapy seem to have…
